about
Essential but not vulnerable: indazole sulfonamides targeting inosine monophosphate dehydrogenase as potential leads against Mycobacterium tuberculosisFitness costs of rifampicin resistance in Mycobacterium tuberculosis are amplified under conditions of nutrient starvation and compensated by mutation in the β' subunit of RNA polymeraseRhabdomyolysis in a patient treated with linezolid for extensively drug-resistant tuberculosis.Linezolid Trough Concentrations Correlate with Mitochondrial Toxicity-Related Adverse Events in the Treatment of Chronic Extensively Drug-Resistant Tuberculosis.Linking High-Throughput Screens to Identify MoAs and Novel Inhibitors of Mycobacterium tuberculosis Dihydrofolate Reductase.Discovery and Structure-Activity-Relationship Study of N-Alkyl-5-hydroxypyrimidinone Carboxamides as Novel Antitubercular Agents Targeting Decaprenylphosphoryl-β-d-ribose 2'-Oxidase.Structures of DPAGT1 Explain Glycosylation Disease Mechanisms and Advance TB Antibiotic DesignInhibition of CorA-Dependent Magnesium Homeostasis Is Cidal in Mycobacterium tuberculosis
P50
Q27644255-9AE1CD5E-8944-46AC-A5A3-D12048B778D4Q30153449-10A2E6C6-67F9-4D7E-84A0-D92DC94F3AEBQ36115648-59C411F6-E595-4538-B6FC-054DCFFA61C3Q36540988-5EAAE83A-FA03-432F-AF92-7A78C359FD82Q38625983-888F677B-C8A8-44C7-AF93-2F3C3D45C096Q57816272-521FCAE3-331A-48C6-9015-E6D63040EF23Q58547177-67BE8950-9784-407A-92CB-4738D98DA406Q92430070-938CCD97-B332-41C2-BCDD-6DB232C6953B
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Yumi Park
@ast
Yumi Park
@en
Yumi Park
@es
Yumi Park
@nl
type
label
Yumi Park
@ast
Yumi Park
@en
Yumi Park
@es
Yumi Park
@nl
prefLabel
Yumi Park
@ast
Yumi Park
@en
Yumi Park
@es
Yumi Park
@nl
P106
P31
P496
0000-0003-2237-0195